221 related articles for article (PubMed ID: 11128558)
1. In vitro antimicrobial activity of propolis dry extract.
Drago L; Mombelli B; De Vecchi E; Fassina MC; Tocalli L; Gismondo MR
J Chemother; 2000 Oct; 12(5):390-5. PubMed ID: 11128558
[TBL] [Abstract][Full Text] [Related]
2. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial activity of soft and purified propolis extracts].
Pavilonis A; Baranauskas A; Puidokaite L; Mazeliene Z; Savickas A; Radziūnas R
Medicina (Kaunas); 2008; 44(12):977-83. PubMed ID: 19142056
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of propolis and its active principles alone and in combination with macrolides, beta-lactams and fluoroquinolones against microorganisms responsible for respiratory infections.
Speciale A; Costanzo R; Puglisi S; Musumeci R; Catania MR; Caccamo F; Iauk L
J Chemother; 2006 Apr; 18(2):164-71. PubMed ID: 16736885
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ertapenem against selected respiratory pathogens.
Marchese A; Gualco L; Schito AM; Debbia EA; Schito GC
J Antimicrob Chemother; 2004 Nov; 54(5):944-51. PubMed ID: 15472001
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial activity of a novel propolis formulation (Actichelated propolis).
Drago L; De Vecchi E; Nicola L; Gismondo MR
J Appl Microbiol; 2007 Nov; 103(5):1914-21. PubMed ID: 17953601
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.
Lofland D; Difuntorum S; Waller A; Clements JM; Weaver MK; Karlowsky JA; Johnson K
J Antimicrob Chemother; 2004 Apr; 53(4):664-8. PubMed ID: 14973152
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
[TBL] [Abstract][Full Text] [Related]
11. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
Wallrauch-Schwarz C; Milatovic D; Braveny I
Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of honey and propolis toward drug multi-resistant Staphylococcus aureus, Escherichia coli and Candida albicans isolates in single and polymicrobial cultures.
Al-Waili N; Al-Ghamdi A; Ansari MJ; Al-Attal Y; Salom K
Int J Med Sci; 2012; 9(9):793-800. PubMed ID: 23136543
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of propolis special extract GH 2002 against multidrug-resistant clinical isolates.
Astani A; Zimmermann S; Hassan E; Reichling J; Sensch KH; Schnitzler P
Pharmazie; 2013 Aug; 68(8):695-701. PubMed ID: 24020127
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries.
Lee MY; Ko KS; Oh WS; Park S; Lee JY; Baek JY; Suh JY; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2006 Jul; 28(1):14-8. PubMed ID: 16777383
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
Nord CE; Lindmark A; Persson I
J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
[No Abstract] [Full Text] [Related]
18. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
19. Activity of the antiseptic polyhexanide against gram-negative bacteria.
Fabry WH; Kock HJ; Vahlensieck W
Microb Drug Resist; 2014 Apr; 20(2):138-43. PubMed ID: 24192397
[TBL] [Abstract][Full Text] [Related]
20. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
Blondeau JM; Suter M; Borsos S
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
